Molecular breast imaging and background uptake of fibroglandular tissue as tools to predict neoplasms in dense breasts
Keywords:
molecular imaging, breast neoplasms, radionuclide imaging, breast densityAbstract
The sensitivity of mammography as a screening method is low in dense breasts, which are associated with a high risk of developing tumors. Thus, molecular breast imaging (MBI) with background uptake (BPU) of fibroglandular tissue can be used as a complementary method. The aim of this review was to synthesize the existing evidence on these important diagnostic imaging tools. Three electronic databases were searched to identify original articles, including publications dating from September 2010 and September 2020, in English, conducted in any location, and addressing at least one aspect related to dense breasts and Breast-specific gamma-imaging (BSGI). In total, 22 studies were reviewed. Several advantages of MBI and BPU as complementary methods of screening for dense breasts were found. Among them, we can mention the increase in breast cancer detection rate, easy implementation in clinical practice, high patient satisfaction, low cost and good reproducibility. In view of the good results found in our review, we can conclude that the implementation of MBI, especially with BPU, can be a promising complementary tool for screening of dense breasts.
Downloads
References
World Health Organization. International Agency for Research on Cancer. Globocan 2018 [Internet]. World Health Organization [cited on Set 14, 2020]. Available from: https://gco.iarc.fr
Hruska CB, Geske JR, Swanson TN, Mammel AN, Lake DS, Manduca A, et al. Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study. Breast Cancer Res. 2018;20(1):46. https://doi.org/10.1186/s13058-018-0973-3
Hruska CB, Geske JR, Conners AL, Whaley DH, Rhodes DJ, O’Connor MK, et al. Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study. Am J Roentgenol. 2021;216(5):1193-204. https://doi.org/10.2214/AJR.20.23854
Critical Appraisal Skills Programme (CASP). [Internet]. Oxford Centre for Triple Value Healthcare; 2019 [cited on Oct 26, 2020]. Available from https://casp-uk.net/casp-tools-checklists
Checklist for Systematic Reviews and Research Syntheses. Critical Appraisal tools for use in JBI Systematic Reviews [Internet]. 2020 [cited on Oct 26, 2020]. Available from: https://joannabriggs.org/critical-appraisal-tools
Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. Am J Roentgenol. 2015;204(2):241-51. https://dx.doi.org/10.2214%2FAJR.14.13357
Brem RF, Ruda RC, Yang JL, Coffey CM, Rapelyea JA. Breast-specific γ-imaging for the detection of mammographically occult breast cancer in women at increased risk. J Nucl Med. 2016;57(5):678-84. https://doi.org/10.2967/jnumed.115.168385
Choi EK, Im JJ, Park CS, Chung YA, Kim K, Oh JK. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy. Eur Radiol. 2018;28(12):5195-202. https://doi.org/10.1007/s00330-018-5563-3
Rechtman LR, Lenihan MJ, Lieberman JH, Teal CB, Torrente J, Rapelyea JA, et al. Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts. Am J Roentgenol. 2014;202(2):293-8. https://doi.org/10.2214/ajr.13.11585
Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: Observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012;39(6):971-82. https://doi.org/10.1007/s00259-011-2054-z
World Health Organization. International Agency for Research on Cancer. Globocan 2018 [Internet]. World Health Organization [cited on Set 14, 2020]. Available from: https://gco.iarc.fr
Hruska CB, Geske JR, Swanson TN, Mammel AN, Lake DS, Manduca A, et al. Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study. Breast Cancer Res. 2018;20(1):46. https://doi.org/10.1186/s13058-018-0973-3
Hruska CB, Geske JR, Conners AL, Whaley DH, Rhodes DJ, O’Connor MK, et al. Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study. Am J Roentgenol. 2021;216(5):1193-204. https://doi.org/10.2214/AJR.20.23854
Critical Appraisal Skills Programme (CASP). [Internet]. Oxford Centre for Triple Value Healthcare; 2019 [cited on Oct 26, 2020]. Available from https://casp-uk.net/casp-tools-checklists
Checklist for Systematic Reviews and Research Syntheses. Critical Appraisal tools for use in JBI Systematic Reviews [Internet]. 2020 [cited on Oct 26, 2020]. Available from: https://joannabriggs.org/critical-appraisal-tools
Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. Am J Roentgenol. 2015;204(2):241-51. https://dx.doi.org/10.2214%2FAJR.14.13357
Brem RF, Ruda RC, Yang JL, Coffey CM, Rapelyea JA. Breast-specific γ-imaging for the detection of mammographically occult breast cancer in women at increased risk. J Nucl Med. 2016;57(5):678-84. https://doi.org/10.2967/jnumed.115.168385
Choi EK, Im JJ, Park CS, Chung YA, Kim K, Oh JK. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy. Eur Radiol. 2018;28(12):5195-202. https://doi.org/10.1007/s00330-018-5563-3
Rechtman LR, Lenihan MJ, Lieberman JH, Teal CB, Torrente J, Rapelyea JA, et al. Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts. Am J Roentgenol. 2014;202(2):293-8. https://doi.org/10.2214/ajr.13.11585
Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: Observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012;39(6):971-82. https://doi.org/10.1007/s00259-011-2054-z
Hruska CB, Hunt KN, Conners AL, Geske JR, Brandt KR, Degnim AC, et al. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: A pilot study. Breast Cancer Res. 2019;21(1):38. https://doi.org/10.1186/s13058-019-1120-5
Yoon HJ, Kim Y, Lee JE, Kim BS. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging. Eur Radiol. 2015;25(1):32-40. https://doi.org/10.1007/s00330-014-3400-x
Ching JG, Brem RF. Breast Lesions Detected via Molecular Breast Imaging: Physiological Parameters Affecting Interpretation. Acad Radiol. 2018;25(12):1568-76. https://doi.org/10.1016/j.acra.2018.03.004
Hruska CB, Rhodes DJ, Conners AL, Jones KN, Carter RE, Lingineni RK, et al. Background parenchymal uptake during molecular breast imaging and associated clinical factors. Am J Roentgenol. 2015;204(3):W363-70. https://doi.org/10.2214/ajr.14.12979
Hruska CB, Conners AL, Vachon CM, O’Connor MK, Shuster LT, Bartley AC, et al. Effect of Menstrual Cycle Phase on Background Parenchymal Uptake at Molecular Breast Imaging. Acad Radiol. 2015;22(9):1147-56. https://dx.doi.org/10.1016%2Fj.acra.2015.04.003
Dibble EH. Editorial Comment on “Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.” Am J Roentgenol. 2021;216(5):1204. https://doi.org/10.2214/AJR.20.24456
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Carla Lima Santos Viviani, Lucimara Priscila Veras, Dionísio Nepomuceno Viviani, Rivadávio Fernandes Batista de Amorim
This work is licensed under a Creative Commons Attribution 4.0 International License.
